UNITED STATES PATENT AND TRADEMARK OFFICE
|
SERIAL NO: 77/112751
MARK: RANEXA
|
|
|
CORRESPONDENT ADDRESS: |
GENERAL TRADEMARK INFORMATION: http://www.gov.uspto.report/main/trademarks.htm
|
|
APPLICANT: CV Therapeutics, Inc.
|
|
|
CORRESPONDENT’S REFERENCE/DOCKET NO: CORRESPONDENT E-MAIL ADDRESS: |
|
EXAMINER’S AMENDMENT
AMENDMENT: In accordance with the authorization granted by Stephanie Wade on August 20, 2007, the application has been AMENDED as indicated below. Please advise the undersigned immediately if there is an objection to the amendment.
If the identification of goods or services has been amended, please note that any future amendments must be in accordance with 37 C.F.R. 2.71(a); TMEP section 1402.07(e).
The identification of goods is amended to read as follows:
Printed materials, namely, pamphlets, brochures, and newsletters about cardiovascular topics, in International Class 16.
TMEP §1402.01(e).
Please note that duplicate Application No. 76560883 has since been abandoned and is no longer a potential bar to registration. The application will now proceed to publication in the Official Gazette
Tarah Hardy Ludlow
Trademark Attorney
Law Office 110
571-272-9361
571-273-9110 fax
STATUS CHECK: Check the status of the application at least once every six months from the initial filing date using the USPTO Trademark Applications and Registrations Retrieval (TARR) online system at http://tarr.uspto.gov. When conducting an online status check, print and maintain a copy of the complete TARR screen. If the status of your application has not changed for more than six months, please contact the assigned examining attorney.